Zydus Cadila gets nod for Acyclovir

Hyderabad: Pharmaceutical major Zydus Cadila said that it has received final approval from United States Food & Drug Administration (USFDA) for marketing of anti-viral drug Acyclovir. Acyclovir is one of the most commonly used antiviral drugs, primarily used for the treatment of herpes simplex virus infections, as well as in the treatment of chickenpox and shingles. The approval has been granted for Acyclovir tablets in strengths of 400 mg and 800 mg, Zydus Cadila said. According to IMS data, the sales of Acyclovir tablets in 2014 are estimated at $55.8 million.